Brimonidine Tartrate Ophthalmic Solution 0.025% with Sodium Hyaluronate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Brimonidine Tartrate Ophthalmic Solution 0.025% with Sodium Hyaluronate, covering 2025-07-09 to 2025-07-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular Redness [Phase 3]